HOME >> BIOLOGY >> NEWS
Replacement warhead program poses challenges for weapons complex

An independent study group, convened by AAASs Center for Science, Technology and Security Policy, has issued a report on the proposed Reliable Replacement Warhead (RRW) and its role in the future U.S. nuclear weapons program.

Bruce Tarter, head of the study group and a former director of the Lawrence Livermore National Laboratory, will discuss the report in a teleconference with reporters at 10:00 a.m. EDT on Tuesday, 24 April.

All details from the teleconference will remain under embargo until 11:00 a.m. EDT, Tuesday, 24 April, 2007. Dial-in numbers: Toll Free 1-800-619-7628 Toll Number for International -- 1-210-234-0019. Leader Name: Ben Somers, passcode: AAAS. (Participants are requested to RSVP to Benjamin Somers prior to the teleconference at bsomers@aaas.org or 202-326-6414.)

The panel concluded that most of the anticipated benefits of the proposed RRW program -- more easily maintained nuclear weapons with enhanced performance margins, improved safety and security properties, and greater ease of manufacture -- would occur in the long term subsequent to modernization of the weapons production complex.

However, the panel noted that the next one to two decades will be a very challenging period for the nuclear weapons program as it simultaneously undertakes construction at many sites, maintenance and refurbishment of existing weapons, and potentially the building of RRWs.

For example the first RRW is provisionally scheduled for delivery in 2012 using the existing production complex which will require a greatly enhanced capability for the manufacture of plutonium pits, or triggers, at the Los Alamos National Laboratory. In addition, certification of both the method and the design for the first RRW will still need to go through a rigorous implementation and demonstration process.

In addition to Tarter, the study group included other former nuclear weapons La
'"/>

Contact: Earl Lane
elane@aaas.org
202-326-6431
American Association for the Advancement of Science
24-Apr-2007


Page: 1 2 3

Related biology news :

1. Malaria-resistant mosquitoes battle disease with molecular warhead
2. New data reveal pregnancies exposed to accutane despite risk management program
3. 50 new mission proposals for ESAs scientific program
4. UD awarded $11M for osteoarthritis research and unique mentoring program for women scientists
5. ESAs water mission instrument passes test program
6. UCLA researchers reprogram normal tissue cells into embryonic stem cells
7. Reprogrammed fibroblasts identical to embryonic stem cells
8. A twist of fate -- Reprogrammed fibroblasts resemble embryonic stem cells
9. Salmon tracking program expands to California
10. Cancer cells reprogram energy needs to grow and spread, study suggests
11. Cooperative science program yields results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: